in open and controlled studies , haloperidol decanoate has produced adequate maintenance or improvement of the condition of patients with psychoses ( mainly schizophrenia ) when an abrupt change from orally administered haloperidol or other antipsychotic drugs has been instituted .
C0062103
haloperidol decanoate
C0036341
schizophrenia